25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Global Cord Blood Corp
Buy, Hold or Sell?

Let's analyze Global Cord Blood Corp together

I guess you are interested in Global Cord Blood Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Global Cord Blood Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Global Cord Blood Corp

I send you an email if I find something interesting about Global Cord Blood Corp.

1. Quick Overview

1.1. Quick analysis of Global Cord Blood Corp (30 sec.)










1.2. What can you expect buying and holding a share of Global Cord Blood Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$0.04
Expected worth in 1 year
$-4.59
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
$-4.63
Return On Investment
-453.6%

For what price can you sell your share?

Current Price per Share
$1.02
Expected price per share
$0.021 - $1.15
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Global Cord Blood Corp (5 min.)




Live pricePrice per Share (EOD)
$1.02
Intrinsic Value Per Share
$-22.60 - $12.73
Total Value Per Share
$-22.56 - $12.77

2.2. Growth of Global Cord Blood Corp (5 min.)




Is Global Cord Blood Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$106.4m$598.3m-$77.1m-14.8%

How much money is Global Cord Blood Corp making?

Current yearPrevious yearGrowGrow %
Making money$16.3m$17.6m-$1.3m-8.3%
Net Profit Margin38.5%42.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Global Cord Blood Corp (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Global Cord Blood Corp?

Welcome investor! Global Cord Blood Corp's management wants to use your money to grow the business. In return you get a share of Global Cord Blood Corp.

First you should know what it really means to hold a share of Global Cord Blood Corp. And how you can make/lose money.

Speculation

The Price per Share of Global Cord Blood Corp is $1.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Global Cord Blood Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Global Cord Blood Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.04. Based on the TTM, the Book Value Change Per Share is $-1.16 per quarter. Based on the YOY, the Book Value Change Per Share is $0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Global Cord Blood Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.010.5%0.109.4%0.1312.9%0.088.1%0.044.3%
Usd Book Value Change Per Share-5.00-490.0%-1.16-113.4%0.1312.7%-0.15-14.6%-0.03-3.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-5.00-490.0%-1.16-113.4%0.1312.7%-0.15-14.6%-0.03-3.0%
Usd Price Per Share2.96-3.92-4.28-5.80-5.41-
Price to Earnings Ratio133.96-39.86-8.08-19,887.73-10,151.92-
Price-to-Total Gains Ratio-0.59-25.86-32.92-69.48-169.74-
Price to Book Ratio74.26-19.21-0.95-5.26-4.13-
Price-to-Total Gains Ratio-0.59-25.86-32.92-69.48-169.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.02
Number of shares980
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.16-0.15
Usd Total Gains Per Share-1.16-0.15
Gains per Quarter (980 shares)-1,133.63-145.59
Gains per Year (980 shares)-4,534.52-582.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4535-45450-582-592
20-9069-90800-1165-1174
30-13604-136150-1747-1756
40-18138-181500-2329-2338
50-22673-226850-2912-2920
60-27207-272200-3494-3502
70-31742-317550-4077-4084
80-36276-362900-4659-4666
90-40811-408250-5241-5248
100-45345-453600-5824-5830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%61.01.00.098.4%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%38.02.00.095.0%49.013.00.079.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%3.00.037.07.5%3.00.059.04.8%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%38.02.00.095.0%49.013.00.079.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Global Cord Blood Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---4.998-1.157-77%0.130-3954%-0.149-97%-0.030-99%
Book Value Per Share--0.0403.703-99%4.468-99%3.763-99%2.702-99%
Current Ratio--10.72610.581+1%10.118+6%9.648+11%7.620+41%
Debt To Asset Ratio--0.4280.430-1%0.446-4%0.456-6%0.529-19%
Debt To Equity Ratio--0.7480.757-1%0.808-7%0.843-11%1.195-37%
Dividend Per Share----0%-0%-0%0.000-100%
Enterprise Value--7968655162.1002717773248.375+193%916738435.350+769%1433211554.700+456%1050795723.340+658%
Eps--0.0060.095-94%0.132-96%0.083-93%0.044-87%
Ev To Ebitda Ratio--101.49033.794+200%10.799+840%23.326+335%21.069+382%
Ev To Sales Ratio--48.53716.381+196%5.542+776%9.364+418%8.290+485%
Free Cash Flow Per Share--0.0000.084-100%0.662-100%0.395-100%0.278-100%
Free Cash Flow To Equity Per Share--0.0000.080-100%0.655-100%0.392-100%0.328-100%
Gross Profit Margin--0.4430.484-8%0.524-15%0.322+38%-0.068+115%
Intrinsic Value_10Y_max--12.727--------
Intrinsic Value_10Y_min---22.598--------
Intrinsic Value_1Y_max--1.446--------
Intrinsic Value_1Y_min--0.543--------
Intrinsic Value_3Y_max--4.214--------
Intrinsic Value_3Y_min---0.790--------
Intrinsic Value_5Y_max--6.826--------
Intrinsic Value_5Y_min---4.767--------
Market Cap136593300.000-5686%7903052000.0002401277912.500+229%573156200.000+1279%1151437562.500+586%912648921.250+766%
Net Profit Margin--0.3590.385-7%0.429-16%0.358+1%0.271+33%
Operating Margin---0.365-100%0.503-100%0.404-100%0.359-100%
Operating Ratio--0.0890.407-78%0.525-83%0.552-84%0.596-85%
Pb Ratio25.591-190%74.26419.213+287%0.954+7686%5.256+1313%4.133+1697%
Pe Ratio46.162-190%133.96139.862+236%8.083+1557%19887.733-99%10151.920-99%
Price Per Share1.020-190%2.9603.918-24%4.280-31%5.796-49%5.414-45%
Price To Free Cash Flow Ratio-15076.547+66%-43751.547-10936.447-75%0.428-10223243%-2182.078-95%-1084.873-98%
Price To Total Gains Ratio-0.204+66%-0.59225.857-102%32.921-102%69.476-101%169.735-100%
Quick Ratio--10.55210.402+1%9.943+6%9.508+11%7.493+41%
Return On Assets--0.0790.031+158%0.016+385%0.017+354%0.013+530%
Return On Equity--0.1390.054+157%0.030+368%0.032+335%0.026+443%
Total Gains Per Share---4.998-1.157-77%0.130-3954%-0.149-97%-0.030-99%
Usd Book Value--106417788.500521208664.950-80%598352913.100-82%509005948.705-79%364397340.588-71%
Usd Book Value Change Per Share---4.998-1.157-77%0.130-3954%-0.149-97%-0.030-99%
Usd Book Value Per Share--0.0403.703-99%4.468-99%3.763-99%2.702-99%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Enterprise Value--7968655162.1002717773248.375+193%916738435.350+769%1433211554.700+456%1050795723.340+658%
Usd Eps--0.0060.095-94%0.132-96%0.083-93%0.044-87%
Usd Free Cash Flow---45158.7005582796.075-101%22148201.800-100%21140921.115-100%25167852.647-100%
Usd Free Cash Flow Per Share--0.0000.084-100%0.662-100%0.395-100%0.278-100%
Usd Free Cash Flow To Equity Per Share--0.0000.080-100%0.655-100%0.392-100%0.328-100%
Usd Market Cap136593300.000-5686%7903052000.0002401277912.500+229%573156200.000+1279%1151437562.500+586%912648921.250+766%
Usd Price Per Share1.020-190%2.9603.918-24%4.280-31%5.796-49%5.414-45%
Usd Profit--14748803.80016323661.675-10%17682289.475-17%14136461.495+4%9163359.658+61%
Usd Revenue--41044562.90042303137.250-3%41219397.5000%38812059.015+6%30681794.385+34%
Usd Total Gains Per Share---4.998-1.157-77%0.130-3954%-0.149-97%-0.030-99%
 EOD+4 -4MRQTTM+15 -23YOY+15 -235Y+20 -1810Y+20 -20

3.3 Fundamental Score

Let's check the fundamental score of Global Cord Blood Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1546.162
Price to Book Ratio (EOD)Between0-125.591
Net Profit Margin (MRQ)Greater than00.359
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than110.552
Current Ratio (MRQ)Greater than110.726
Debt to Asset Ratio (MRQ)Less than10.428
Debt to Equity Ratio (MRQ)Less than10.748
Return on Equity (MRQ)Greater than0.150.139
Return on Assets (MRQ)Greater than0.050.079
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Global Cord Blood Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.931
Ma 20Greater thanMa 500.961
Ma 50Greater thanMa 1001.019
Ma 100Greater thanMa 2001.125
OpenGreater thanClose1.020
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Global Cord Blood Corp

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Fundamental data was last updated by Penke on 2025-02-28 10:53:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Global Cord Blood Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Global Cord Blood Corp to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 35.9% means that $0.36 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Global Cord Blood Corp:

  • The MRQ is 35.9%. The company is making a huge profit. +2
  • The TTM is 38.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ35.9%TTM38.5%-2.6%
TTM38.5%YOY42.9%-4.4%
TTM38.5%5Y35.8%+2.7%
5Y35.8%10Y27.1%+8.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ35.9%-2.6%+38.5%
TTM38.5%-10.3%+48.8%
YOY42.9%1.3%+41.6%
5Y35.8%-3.0%+38.8%
10Y27.1%0.7%+26.4%
4.3.1.2. Return on Assets

Shows how efficient Global Cord Blood Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Global Cord Blood Corp to the Diagnostics & Research industry mean.
  • 7.9% Return on Assets means that Global Cord Blood Corp generated $0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Global Cord Blood Corp:

  • The MRQ is 7.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 3.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.9%TTM3.1%+4.9%
TTM3.1%YOY1.6%+1.4%
TTM3.1%5Y1.7%+1.3%
5Y1.7%10Y1.3%+0.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9%-1.3%+9.2%
TTM3.1%-1.7%+4.8%
YOY1.6%-0.5%+2.1%
5Y1.7%-+1.7%
10Y1.3%-0.2%+1.5%
4.3.1.3. Return on Equity

Shows how efficient Global Cord Blood Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Global Cord Blood Corp to the Diagnostics & Research industry mean.
  • 13.9% Return on Equity means Global Cord Blood Corp generated $0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Global Cord Blood Corp:

  • The MRQ is 13.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.9%TTM5.4%+8.5%
TTM5.4%YOY3.0%+2.4%
TTM5.4%5Y3.2%+2.2%
5Y3.2%10Y2.6%+0.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ13.9%0.1%+13.8%
TTM5.4%-2.2%+7.6%
YOY3.0%0.3%+2.7%
5Y3.2%-0.2%+3.4%
10Y2.6%-0.9%+3.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Global Cord Blood Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Global Cord Blood Corp is operating .

  • Measures how much profit Global Cord Blood Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Global Cord Blood Corp to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Global Cord Blood Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM36.5%-36.5%
TTM36.5%YOY50.3%-13.8%
TTM36.5%5Y40.4%-3.9%
5Y40.4%10Y35.9%+4.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.1%+16.1%
TTM36.5%-20.2%+56.7%
YOY50.3%2.6%+47.7%
5Y40.4%-0.3%+40.7%
10Y35.9%2.9%+33.0%
4.3.2.2. Operating Ratio

Measures how efficient Global Cord Blood Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.09 means that the operating costs are $0.09 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Global Cord Blood Corp:

  • The MRQ is 0.089. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.407. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.089TTM0.407-0.318
TTM0.407YOY0.525-0.118
TTM0.4075Y0.552-0.146
5Y0.55210Y0.596-0.044
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0891.246-1.157
TTM0.4071.283-0.876
YOY0.5251.252-0.727
5Y0.5521.230-0.678
10Y0.5961.210-0.614
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Global Cord Blood Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Global Cord Blood Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 10.73 means the company has $10.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Global Cord Blood Corp:

  • The MRQ is 10.726. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.581. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.726TTM10.581+0.145
TTM10.581YOY10.118+0.463
TTM10.5815Y9.648+0.933
5Y9.64810Y7.620+2.028
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ10.7262.046+8.680
TTM10.5812.060+8.521
YOY10.1182.548+7.570
5Y9.6482.646+7.002
10Y7.6203.241+4.379
4.4.3.2. Quick Ratio

Measures if Global Cord Blood Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Global Cord Blood Corp to the Diagnostics & Research industry mean.
  • A Quick Ratio of 10.55 means the company can pay off $10.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Global Cord Blood Corp:

  • The MRQ is 10.552. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.402. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.552TTM10.402+0.150
TTM10.402YOY9.943+0.459
TTM10.4025Y9.508+0.894
5Y9.50810Y7.493+2.015
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ10.5521.200+9.352
TTM10.4021.265+9.137
YOY9.9431.632+8.311
5Y9.5081.983+7.525
10Y7.4932.404+5.089
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Global Cord Blood Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Global Cord Blood Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Global Cord Blood Corp to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.43 means that Global Cord Blood Corp assets are financed with 42.8% credit (debt) and the remaining percentage (100% - 42.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Global Cord Blood Corp:

  • The MRQ is 0.428. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.430. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.428TTM0.430-0.003
TTM0.430YOY0.446-0.016
TTM0.4305Y0.456-0.026
5Y0.45610Y0.529-0.073
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4280.442-0.014
TTM0.4300.442-0.012
YOY0.4460.382+0.064
5Y0.4560.414+0.042
10Y0.5290.443+0.086
4.5.4.2. Debt to Equity Ratio

Measures if Global Cord Blood Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Global Cord Blood Corp to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 74.8% means that company has $0.75 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Global Cord Blood Corp:

  • The MRQ is 0.748. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.757. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.748TTM0.757-0.009
TTM0.757YOY0.808-0.050
TTM0.7575Y0.843-0.085
5Y0.84310Y1.195-0.352
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7480.616+0.132
TTM0.7570.636+0.121
YOY0.8080.512+0.296
5Y0.8430.686+0.157
10Y1.1950.725+0.470
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Global Cord Blood Corp generates.

  • Above 15 is considered overpriced but always compare Global Cord Blood Corp to the Diagnostics & Research industry mean.
  • A PE ratio of 133.96 means the investor is paying $133.96 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Global Cord Blood Corp:

  • The EOD is 46.162. Based on the earnings, the company is overpriced. -1
  • The MRQ is 133.961. Based on the earnings, the company is expensive. -2
  • The TTM is 39.862. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD46.162MRQ133.961-87.799
MRQ133.961TTM39.862+94.099
TTM39.862YOY8.083+31.779
TTM39.8625Y19,887.733-19,847.872
5Y19,887.73310Y10,151.920+9,735.813
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD46.162-0.218+46.380
MRQ133.961-0.693+134.654
TTM39.862-0.897+40.759
YOY8.0830.034+8.049
5Y19,887.7331.418+19,886.315
10Y10,151.9207.009+10,144.911
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Global Cord Blood Corp:

  • The EOD is -15,076.547. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -43,751.547. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10,936.447. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15,076.547MRQ-43,751.547+28,675.001
MRQ-43,751.547TTM-10,936.447-32,815.101
TTM-10,936.447YOY0.428-10,936.875
TTM-10,936.4475Y-2,182.078-8,754.369
5Y-2,182.07810Y-1,084.873-1,097.204
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-15,076.547-0.117-15,076.430
MRQ-43,751.547-0.016-43,751.531
TTM-10,936.447-0.714-10,935.733
YOY0.428-2.367+2.795
5Y-2,182.078-1.205-2,180.873
10Y-1,084.873-2.103-1,082.770
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Global Cord Blood Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 74.26 means the investor is paying $74.26 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Global Cord Blood Corp:

  • The EOD is 25.591. Based on the equity, the company is expensive. -2
  • The MRQ is 74.264. Based on the equity, the company is expensive. -2
  • The TTM is 19.213. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD25.591MRQ74.264-48.673
MRQ74.264TTM19.213+55.052
TTM19.213YOY0.954+18.259
TTM19.2135Y5.256+13.956
5Y5.25610Y4.133+1.123
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD25.5911.955+23.636
MRQ74.2642.222+72.042
TTM19.2132.222+16.991
YOY0.9542.264-1.310
5Y5.2563.607+1.649
10Y4.1334.140-0.007
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Global Cord Blood Corp.

4.8.1. Institutions holding Global Cord Blood Corp

Institutions are holding 10.578% of the shares of Global Cord Blood Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-03-31Oasis Management Co. Ltd5.0763.2594679757400
2023-03-31Renaissance Technologies Corp1.75380.0009234854900
2023-03-31Man Group PLC1.34510.0191180133600
2023-03-31BlueCrest Capital Management Ltd.0.55920.07374888900
2023-03-31Quinn Opportunity Partners LLC0.2423032449400
2023-03-31IsZo Capital Management LP0.2087027949500
2023-03-31Natixis Advisors, LLC.0.15020.002120115100
2023-03-31Bank of America Corp0.13140.000117595900
2023-03-31Morgan Stanley - Brokerage Accounts0.06508706400
2023-03-31Benjamin F. Edwards & Company, Llc0.044105905300
2023-03-31Northern Trust Corp0.023603157900
2023-03-31Moneta Group Investment Advisors Inc0.01950.00192609400
2023-03-31American Century Companies Inc0.01540.00012059100
2023-03-31Susquehanna International Group, LLP0.0101333300
2023-03-31Marshall Wace Asset Management Ltd0.009201233200
2023-03-31CLARK FINANCIAL SERVICES GROUP INC /BD0.00920.054612275122750
2023-03-31Two Sigma Advisers, LLC0.00850.00011140000
2023-03-31Citadel Advisors Llc0.008101080000
2023-03-31UMB Bank NA0.0030.0002397800
2023-03-31UBS Group AG0.00090123800
Total 9.68323.411512967184+12275+0.1%

4.9.2. Funds holding Global Cord Blood Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-03-31Man GLG Event Driven Alternative IN USD0.79740.2476106788368700.6475
2023-06-30Wealth Invest L&P Dividende Fond0.12150.477916265000
2023-06-30Wealth Invest L&P Global Value Fond0.120.546916064000
2022-11-30MW Asset Management MW Optimum CR-P Cap0.08658.686111584000
2023-04-30Parametric International Equity I0.022102960000
2023-06-30Avantis® Emerging Markets Equity ETF0.01390.00061857100
2023-05-31Cinvest Azero Global FI0.007501000000
2023-05-31Base Inv Macro Dynamic EUR0.00520700000
2023-03-31Northern Small Cap Core K0.00470.0046634600
2023-05-31Avantis® Emerging Markets Equity Instl0.00150.002202000
Total 1.18039.96571580550+6870+0.4%

5.3. Insider Transactions

DateOwnerTypeAmountPricePost Transaction AmountLink
2016-01-05Gordon Scott Townsen MckinnonBUY5000000.02 
2015-09-30Fraser James LaschingerBUY800000.02 
2015-09-30Gordon Scott Townsen MckinnonBUY500000.02 
2015-09-29Gordon Scott Townsen MckinnonBUY10000.03 
2015-01-21Kent C MccarthyBUY200004.6
2015-01-16Kent C MccarthyBUY500004.3
2015-01-14Private Equity Fund Jayhawk IiBUY100004.52
2015-01-12Private Equity Fund Jayhawk IiBUY500004.69
2014-11-28Robert Douglas CudneyBUY2000000.01 
2014-11-17Kent C MccarthyBUY267544.7
2014-11-06Kent C MccarthyBUY1500005.16
2014-09-29Kent C MccarthyBUY100005
2014-09-10Kent C MccarthyBUY99004.98
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Total Operating Expenses  15,298-52014,7781,82216,600-98115,618-17,749-2,131



5.2. Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,346,288
Total Liabilities575,703
Total Stockholder Equity769,693
 As reported
Total Liabilities 575,703
Total Stockholder Equity+ 769,693
Total Assets = 1,346,288

Assets

Total Assets1,346,288
Total Current Assets1,093,971
Long-term Assets252,317
Total Current Assets
Cash And Cash Equivalents 1,050,744
Net Receivables 25,445
Inventory 7,237
Other Current Assets 10,545
Total Current Assets  (as reported)1,093,971
Total Current Assets  (calculated)1,093,971
+/-0
Long-term Assets
Property Plant Equipment 75,196
Intangible Assets 13,184
Long-term Assets Other 163,937
Long-term Assets  (as reported)252,317
Long-term Assets  (calculated)252,317
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities101,992
Long-term Liabilities473,711
Total Stockholder Equity769,693
Total Current Liabilities
Accounts payable 1,314
Other Current Liabilities 28,389
Total Current Liabilities  (as reported)101,992
Total Current Liabilities  (calculated)29,703
+/- 72,289
Long-term Liabilities
Long-term Liabilities  (as reported)473,711
Long-term Liabilities  (calculated)0
+/- 473,711
Total Stockholder Equity
Retained Earnings 455,453
Other Stockholders Equity 314,240
Total Stockholder Equity (as reported)769,693
Total Stockholder Equity (calculated)769,693
+/-0
Other
Cash and Short Term Investments 1,050,744
Common Stock Shares Outstanding 2,669,950
Current Deferred Revenue72,289
Liabilities and Stockholders Equity 1,345,396
Net Debt -1,050,721
Net Working Capital 991,979
Short Long Term Debt Total 23



5.3. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-31
> Total Assets 
260,624
257,584
255,326
249,697
240,442
235,550
235,472
196,991
197,289
116,917
838,317
1,009,936
1,047,034
1,083,435
1,129,442
1,371,778
1,563,598
1,637,693
1,598,182
1,671,930
1,824,150
2,270,663
2,420,350
2,841,011
2,986,276
3,106,279
3,290,992
3,457,703
3,631,022
3,730,952
3,867,970
3,978,538
4,119,486
4,245,864
4,369,905
4,585,338
4,687,927
4,808,043
4,850,711
5,042,755
5,182,912
5,375,435
5,565,187
5,696,503
5,844,435
6,028,069
6,197,580
6,324,770
6,550,954
6,738,485
6,951,152
7,111,494
7,219,853
7,396,776
7,572,920
7,715,566
7,906,329
8,094,956
8,258,258
8,397,726
8,534,525
1,346,288
1,346,2888,534,5258,397,7268,258,2588,094,9567,906,3297,715,5667,572,9207,396,7767,219,8537,111,4946,951,1526,738,4856,550,9546,324,7706,197,5806,028,0695,844,4355,696,5035,565,1875,375,4355,182,9125,042,7554,850,7114,808,0434,687,9274,585,3384,369,9054,245,8644,119,4863,978,5383,867,9703,730,9523,631,0223,457,7033,290,9923,106,2792,986,2762,841,0112,420,3502,270,6631,824,1501,671,9301,598,1821,637,6931,563,5981,371,7781,129,4421,083,4351,047,0341,009,936838,317116,917197,289196,991235,472235,550240,442249,697255,326257,584260,624
   > Total Current Assets 
260,624
257,584
255,326
249,697
239,748
234,871
234,802
196,991
197,289
0
327,196
462,458
363,834
399,791
417,030
642,751
710,873
788,744
749,452
823,109
897,172
1,284,303
1,431,830
1,588,951
1,598,174
1,667,771
1,791,206
1,895,309
2,058,047
2,159,316
2,321,448
2,474,350
2,622,298
2,743,801
2,867,121
3,069,144
3,199,861
3,247,779
3,318,672
3,530,731
3,671,308
3,889,359
4,102,593
4,248,027
4,408,422
4,588,070
4,774,079
4,928,540
5,147,928
5,305,298
5,512,085
5,547,091
5,666,167
5,809,157
5,974,935
6,111,042
6,298,141
6,476,693
6,648,463
6,782,199
6,935,003
1,093,971
1,093,9716,935,0036,782,1996,648,4636,476,6936,298,1416,111,0425,974,9355,809,1575,666,1675,547,0915,512,0855,305,2985,147,9284,928,5404,774,0794,588,0704,408,4224,248,0274,102,5933,889,3593,671,3083,530,7313,318,6723,247,7793,199,8613,069,1442,867,1212,743,8012,622,2982,474,3502,321,4482,159,3162,058,0471,895,3091,791,2061,667,7711,598,1741,588,9511,431,8301,284,303897,172823,109749,452788,744710,873642,751417,030399,791363,834462,458327,1960197,289196,991234,802234,871239,748249,697255,326257,584260,624
       Cash And Cash Equivalents 
255,751
609
785
2,478
451
384
5
129
36
33,462
247,813
386,069
280,835
323,315
338,641
548,017
611,387
643,088
635,698
716,724
794,311
1,146,682
1,324,507
1,480,842
1,494,099
1,560,024
1,669,380
1,754,558
1,882,901
1,989,506
2,156,527
2,295,598
2,436,655
2,560,907
2,671,772
2,873,740
3,008,422
3,070,419
3,142,647
3,316,963
3,510,264
3,724,699
3,927,280
4,078,303
4,250,610
4,423,165
4,611,250
4,781,591
4,997,861
5,162,037
5,368,285
5,386,386
5,473,373
5,565,529
5,729,503
5,867,754
6,075,798
6,237,406
6,390,632
6,505,014
6,660,984
1,050,744
1,050,7446,660,9846,505,0146,390,6326,237,4066,075,7985,867,7545,729,5035,565,5295,473,3735,386,3865,368,2855,162,0374,997,8614,781,5914,611,2504,423,1654,250,6104,078,3033,927,2803,724,6993,510,2643,316,9633,142,6473,070,4193,008,4222,873,7402,671,7722,560,9072,436,6552,295,5982,156,5271,989,5061,882,9011,754,5581,669,3801,560,0241,494,0991,480,8421,324,5071,146,682794,311716,724635,698643,088611,387548,017338,641323,315280,835386,069247,81333,4623612953844512,478785609255,751
       Short-term Investments 
4,015
3,079
1,821
1,061
1,413
657
234,714
196,802
197,198
0
0
0
0
0
0
0
0
357
332
335
354
0
0
0
0
0
0
0
1,243
0
0
7,571
7,708
7,841
7,861
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000007,8617,8417,7087,571001,243000000035433533235700000000197,198196,802234,7146571,4131,0611,8213,0794,015
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
64,274
57,071
61,349
53,902
56,609
66,797
78,561
87,459
85,483
79,898
79,012
80,349
78,627
77,894
75,306
75,425
80,559
86,361
111,690
101,900
110,412
117,276
125,944
119,653
124,978
128,079
131,763
120,720
118,523
161,014
117,800
111,469
111,697
108,908
117,034
104,583
104,709
96,846
107,707
96,294
97,060
98,102
110,276
111,635
121,722
128,962
135,074
135,415
144,667
154,074
161,302
25,445
25,445161,302154,074144,667135,415135,074128,962121,722111,635110,27698,10297,06096,294107,70796,846104,709104,583117,034108,908111,697111,469117,800161,014118,523120,720131,763128,079124,978119,653125,944117,276110,412101,900111,69086,36180,55975,42575,30677,89478,62780,34979,01279,89885,48387,45978,56166,79756,60953,90261,34957,07164,2740000000000
       Other Current Assets 
858
253,896
252,721
246,157
237,883
233,830
83
60
55
4,757
9,898
13,561
16,580
14,939
15,289
17,798
14,196
50,154
17,060
17,037
16,829
51,661
23,622
22,844
18,504
21,552
24,435
31,071
31,873
38,902
28,898
30,650
28,188
29,836
33,384
36,621
31,350
30,455
30,389
24,465
12,257
17,397
24,860
25,546
13,060
22,828
25,582
27,064
14,748
21,615
19,340
28,235
38,760
79,533
67,604
57,231
43,012
66,912
79,343
75,721
11,938
10,545
10,54511,93875,72179,34366,91243,01257,23167,60479,53338,76028,23519,34021,61514,74827,06425,58222,82813,06025,54624,86017,39712,25724,46530,38930,45531,35036,62133,38429,83628,18830,65028,89838,90231,87331,07124,43521,55218,50422,84423,62251,66116,82917,03717,06050,15414,19617,79815,28914,93916,58013,5619,8984,757556083233,830237,883246,157252,721253,896858
   > Long-term Assets 
0
0
0
0
694
679
671
0
0
0
511,121
547,478
683,200
683,644
712,412
729,027
852,725
848,949
848,730
848,821
926,978
986,360
988,520
1,252,060
1,388,102
1,438,508
1,499,786
1,562,394
1,572,975
1,571,636
1,546,522
1,504,188
1,497,188
1,502,063
1,502,784
1,516,194
1,488,066
1,560,264
1,532,039
1,512,024
1,511,604
1,486,076
1,462,594
1,448,476
1,436,013
1,439,999
1,423,501
1,396,230
1,403,026
1,433,187
1,439,067
1,564,403
1,553,686
1,587,619
1,597,985
1,604,524
1,608,188
1,618,263
1,609,795
1,615,527
1,599,522
252,317
252,3171,599,5221,615,5271,609,7951,618,2631,608,1881,604,5241,597,9851,587,6191,553,6861,564,4031,439,0671,433,1871,403,0261,396,2301,423,5011,439,9991,436,0131,448,4761,462,5941,486,0761,511,6041,512,0241,532,0391,560,2641,488,0661,516,1941,502,7841,502,0631,497,1881,504,1881,546,5221,571,6361,572,9751,562,3941,499,7861,438,5081,388,1021,252,060988,520986,360926,978848,821848,730848,949852,725729,027712,412683,644683,200547,478511,1210006716796940000
       Property Plant Equipment 
0
0
0
0
28,701
0
0
0
34,661
36,541
251,574
256,331
250,491
247,836
246,756
251,372
250,348
244,800
243,316
245,011
267,862
347,847
345,279
382,216
468,272
503,775
520,169
600,413
626,632
618,553
616,545
610,453
603,167
596,161
590,061
582,012
574,567
569,128
561,832
560,058
551,434
545,684
541,612
556,757
552,960
548,803
543,451
546,839
545,340
547,351
540,719
535,693
527,227
520,648
520,242
514,497
503,695
493,307
488,403
483,663
476,691
75,196
75,196476,691483,663488,403493,307503,695514,497520,242520,648527,227535,693540,719547,351545,340546,839543,451548,803552,960556,757541,612545,684551,434560,058561,832569,128574,567582,012590,061596,161603,167610,453616,545618,553626,632600,413520,169503,775468,272382,216345,279347,847267,862245,011243,316244,800250,348251,372246,756247,836250,491256,331251,57436,54134,66100028,7010000
       Long Term Investments 
0
0
0
0
0
99
98
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
278,000
0
0
0
333,376
0
0
0
311,545
0
0
0
351,863
417,000
407,274
376,598
56,616
373,958
352,167
351,757
8,696
51,245
6,689
19
296,491
309,572
306,488
312,545
290,435
308,556
309,799
311,080
307,040
311,004
298,103
296,855
282,303
0
0282,303296,855298,103311,004307,040311,080309,799308,556290,435312,545306,488309,572296,491196,68951,2458,696351,757352,167373,95856,616376,598407,274417,000351,863000311,545000333,376000278,00000000000000000000989900000
       Intangible Assets 
0
0
0
0
4,027
0
0
0
3,992
3,957
26,783
26,540
26,297
26,054
25,812
25,569
134,412
133,257
132,102
130,947
129,791
128,636
127,481
126,326
125,170
124,015
122,860
121,704
120,549
119,394
118,239
117,084
115,928
114,773
113,618
112,463
111,307
110,152
108,997
107,842
106,686
105,531
104,376
103,221
102,065
100,910
99,755
98,600
97,444
96,289
95,134
93,978
92,823
91,668
90,513
89,357
88,202
87,047
85,892
84,737
83,581
13,184
13,18483,58184,73785,89287,04788,20289,35790,51391,66892,82393,97895,13496,28997,44498,60099,755100,910102,065103,221104,376105,531106,686107,842108,997110,152111,307112,463113,618114,773115,928117,084118,239119,394120,549121,704122,860124,015125,170126,326127,481128,636129,791130,947132,102133,257134,41225,56925,81226,05426,29726,54026,7833,9573,9920004,0270000
       Other Assets 
0
0
0
0
24,881
0
0
0
33,990
32,881
38,023
42,653
63,393
64,264
69,600
72,371
91,990
93,472
94,922
95,935
104,663
100,505
102,349
139,620
148,102
152,301
160,068
158,908
152,233
153,633
151,511
144,045
144,220
146,113
143,609
144,212
141,671
149,135
145,492
137,111
20,254
138,716
138,425
137,055
11,104
67,274
9,849
30
358,894
368,558
373,435
622,187
643,201
666,747
677,431
689,590
709,251
726,905
737,397
750,272
756,947
0
0756,947750,272737,397726,905709,251689,590677,431666,747643,201622,187373,435368,558358,894309,84967,27411,104137,055138,425138,71620,254137,111145,492149,135141,671144,212143,609146,113144,220144,045151,511153,633152,233158,908160,068152,301148,102139,620102,349100,505104,66395,93594,92293,47291,99072,37169,60064,26463,39342,65338,02332,88133,99000024,8810000
> Total Liabilities 
54,107
53,725
53,632
52,256
50,615
49,708
51,021
56,709
58,773
28,993
208,972
217,608
227,426
248,017
273,606
306,680
470,206
511,059
485,120
524,443
588,523
1,055,933
1,218,503
1,637,602
1,744,813
1,800,614
1,898,300
2,047,377
2,191,026
2,256,327
2,374,008
2,480,932
2,576,273
2,663,642
2,754,165
2,887,300
2,974,502
3,076,566
3,098,282
3,272,935
3,340,363
2,455,565
2,583,908
2,635,029
2,725,693
2,875,027
2,916,049
2,980,646
3,128,192
3,195,442
3,273,242
3,318,370
3,331,362
3,374,299
3,421,323
3,450,101
3,517,878
3,569,465
3,604,854
3,610,129
3,649,553
575,703
575,7033,649,5533,610,1293,604,8543,569,4653,517,8783,450,1013,421,3233,374,2993,331,3623,318,3703,273,2423,195,4423,128,1922,980,6462,916,0492,875,0272,725,6932,635,0292,583,9082,455,5653,340,3633,272,9353,098,2823,076,5662,974,5022,887,3002,754,1652,663,6422,576,2732,480,9322,374,0082,256,3272,191,0262,047,3771,898,3001,800,6141,744,8131,637,6021,218,5031,055,933588,523524,443485,120511,059470,206306,680273,606248,017227,426217,608208,97228,99358,77356,70951,02149,70850,61552,25653,63253,72554,107
   > Total Current Liabilities 
3,565
3,950
4,561
4,435
4,704
4,831
6,205
12,037
14,034
15,347
111,947
114,824
116,034
124,837
133,310
143,231
250,612
253,008
181,239
178,500
197,107
194,495
284,814
302,895
332,448
314,373
319,375
358,092
397,337
365,786
397,347
407,623
420,177
423,723
395,164
437,197
468,323
465,350
950,575
1,443,648
1,447,128
470,428
503,997
458,019
468,175
544,587
511,711
510,571
595,642
594,188
606,461
595,090
570,778
579,985
595,203
591,480
626,469
644,553
650,778
636,494
646,558
101,992
101,992646,558636,494650,778644,553626,469591,480595,203579,985570,778595,090606,461594,188595,642510,571511,711544,587468,175458,019503,997470,4281,447,1281,443,648950,575465,350468,323437,197395,164423,723420,177407,623397,347365,786397,337358,092319,375314,373332,448302,895284,814194,495197,107178,500181,239253,008250,612143,231133,310124,837116,034114,824111,94715,34714,03412,0376,2054,8314,7044,4354,5613,9503,565
       Short-term Debt 
0
0
0
0
0
0
0
1,455
0
0
48,510
45,000
45,000
45,000
45,000
45,000
45,000
45,000
45,000
45,000
45,000
0
50,000
50,000
50,000
50,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
0
60,000
60,000
60,000
553,395
1,024,669
1,031,154
0
0
0
0
0
0
0
0
2,174
2,149
3,354
1,717
1,738
1,597
3,116
1,636
1,655
1,675
1,695
147
0
01471,6951,6751,6551,6363,1161,5971,7381,7173,3542,1492,174000000001,031,1541,024,669553,39560,00060,00060,000060,00060,00060,00060,00060,00060,00060,00060,00050,00050,00050,00050,000045,00045,00045,00045,00045,00045,00045,00045,00045,00045,00048,510001,4550000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
802,000
0
0
0
837,753
0
0
0
868,049
0
0
0
966,222
1,008,000
967,887
1,024,669
149,723
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000149,7231,024,669967,8871,008,000966,222000868,049000837,753000802,000000000000000000000000000
       Accounts payable 
4
0
0
0
527
91
254
1,088
751
853
6,681
8,693
8,387
9,509
7,377
10,251
5,046
5,919
8,646
9,893
6,343
8,956
14,234
16,914
9,890
10,556
8,779
11,999
10,422
14,957
15,624
16,022
12,673
14,989
15,987
11,357
13,248
13,345
11,529
10,669
11,060
14,251
13,125
13,535
11,372
15,729
21,582
13,379
33,566
28,522
29,891
15,615
19,992
14,307
12,317
9,743
9,479
13,883
13,442
11,674
8,330
1,314
1,3148,33011,67413,44213,8839,4799,74312,31714,30719,99215,61529,89128,52233,56613,37921,58215,72911,37213,53513,12514,25111,06010,66911,52913,34513,24811,35715,98714,98912,67316,02215,62414,95710,42211,9998,77910,5569,89016,91414,2348,9566,3439,8938,6465,9195,04610,2517,3779,5098,3878,6936,6818537511,088254915270004
       Other Current Liabilities 
3,561
3,950
4,561
4,435
4,704
4,831
4,102
8,327
11,751
6,843
27,829
26,082
26,573
27,193
27,563
29,738
118,247
121,524
40,441
32,282
39,654
55,730
69,084
88,373
100,230
77,626
69,168
105,326
130,483
92,112
113,572
107,725
127,364
109,562
131,340
126,176
137,383
118,857
92,962
105,166
81,224
109,103
115,960
84,939
90,430
160,567
102,178
102,123
100,090
119,090
130,806
139,766
146,318
159,535
160,773
155,271
165,995
175,356
184,639
171,151
179,819
28,389
28,389179,819171,151184,639175,356165,995155,271160,773159,535146,318139,766130,806119,090100,090102,123102,178160,56790,43084,939115,960109,10381,224105,16692,962118,857137,383126,176131,340109,562127,364107,725113,57292,112130,483105,32669,16877,626100,23088,37369,08455,73039,65432,28240,441121,524118,24729,73827,56327,19326,57326,08227,8296,84311,7518,3274,1024,8314,7044,4354,5613,9503,561
   > Long-term Liabilities 
50,542
49,774
49,071
47,821
45,911
44,877
44,816
44,671
44,739
0
97,025
102,784
111,392
123,180
140,296
163,449
219,594
258,051
303,881
345,943
391,416
861,438
933,689
1,334,707
1,412,365
1,486,241
1,578,925
1,689,285
1,793,689
1,890,541
1,976,661
2,073,309
2,156,096
2,239,919
2,359,001
2,450,103
2,506,179
2,611,216
2,147,707
1,829,287
1,893,235
1,985,137
2,079,911
2,177,010
2,257,518
2,330,440
2,404,338
2,470,075
2,532,550
2,601,254
2,666,781
2,723,280
2,760,584
2,794,314
2,826,120
2,858,621
2,891,409
2,924,912
2,954,076
2,973,635
3,002,995
473,711
473,7113,002,9952,973,6352,954,0762,924,9122,891,4092,858,6212,826,1202,794,3142,760,5842,723,2802,666,7812,601,2542,532,5502,470,0752,404,3382,330,4402,257,5182,177,0102,079,9111,985,1371,893,2351,829,2872,147,7072,611,2162,506,1792,450,1032,359,0012,239,9192,156,0962,073,3091,976,6611,890,5411,793,6891,689,2851,578,9251,486,2411,412,3651,334,707933,689861,438391,416345,943303,881258,051219,594163,449140,296123,180111,392102,78497,025044,73944,67144,81644,87745,91147,82149,07149,77450,542
       Other Liabilities 
0
0
0
0
12,251
0
0
0
12,852
13,130
13,737
14,644
15,989
17,882
20,844
24,765
29,428
35,866
43,620
50,975
58,271
66,323
77,618
90,438
102,631
116,048
130,585
148,769
158,934
173,272
187,699
199,654
212,128
223,984
229,949
235,054
244,598
246,816
256,607
257,712
39,485
289,685
309,460
331,394
57,233
349,496
50,959
160
2,532,550
2,597,763
2,663,459
2,721,468
2,758,802
2,792,560
2,824,396
2,858,426
2,891,262
2,924,813
2,954,026
2,973,635
3,002,995
0
03,002,9952,973,6352,954,0262,924,8132,891,2622,858,4262,824,3962,792,5602,758,8022,721,4682,663,4592,597,7632,532,55016050,959349,49657,233331,394309,460289,68539,485257,712256,607246,816244,598235,054229,949223,984212,128199,654187,699173,272158,934148,769130,585116,048102,63190,43877,61866,32358,27150,97543,62035,86629,42824,76520,84417,88215,98914,64413,73713,13012,85200012,2510000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,000
0
0
0
7,854
0
0
0
181,409
0
0
0
210,020
0
0
0
33,520
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000033,520000210,020000181,4090007,85400012,000000000000000000000000000
> Total Stockholder Equity
206,517
203,859
201,694
197,441
189,827
185,842
184,451
140,282
138,516
87,924
621,332
783,063
808,886
823,263
841,963
1,044,110
1,070,781
1,101,098
1,084,846
1,117,021
1,202,734
1,179,050
1,163,495
1,199,145
1,237,132
1,301,181
1,388,094
1,405,535
1,435,042
1,469,813
1,489,157
1,492,576
1,537,758
1,576,825
1,610,108
1,692,007
1,709,253
1,726,866
1,747,156
1,764,360
1,837,855
2,914,351
2,974,659
3,054,572
3,113,353
3,146,685
3,274,112
3,336,300
3,417,335
3,536,032
3,669,185
3,783,245
3,882,127
4,014,197
4,141,429
4,253,710
4,381,858
4,516,333
4,641,840
4,774,668
4,879,316
769,693
769,6934,879,3164,774,6684,641,8404,516,3334,381,8584,253,7104,141,4294,014,1973,882,1273,783,2453,669,1853,536,0323,417,3353,336,3003,274,1123,146,6853,113,3533,054,5722,974,6592,914,3511,837,8551,764,3601,747,1561,726,8661,709,2531,692,0071,610,1081,576,8251,537,7581,492,5761,489,1571,469,8131,435,0421,405,5351,388,0941,301,1811,237,1321,199,1451,163,4951,179,0501,202,7341,117,0211,084,8461,101,0981,070,7811,044,110841,963823,263808,886783,063621,33287,924138,516140,282184,451185,842189,827197,441201,694203,859206,517
   Common Stock
5
5
5
5
5
5
5
4
4
6
43
45
46
46
46
52
52
51
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
78
78
78
83
83
83
83
83
83
83
83
83
83
83
83
83
83
83
83
83
0
08383838383838383838383838383838383787878505050505050505050505050505050505050505050505051525246464645436445555555
   Retained Earnings 
894
1,359
2,058
2,889
3,044
3,267
2,123
-5,180
-7,168
3,068
51,160
71,161
87,290
104,876
126,859
152,734
178,993
219,015
242,264
281,734
310,973
342,066
366,761
400,392
423,420
456,326
481,230
515,784
555,323
585,059
612,308
645,692
662,615
676,166
694,889
745,341
753,585
769,307
785,948
841,835
879,775
948,910
1,016,505
1,086,359
1,116,873
1,189,641
1,254,755
1,316,115
1,407,223
1,515,567
1,635,920
1,780,933
1,877,940
2,010,449
2,141,883
2,258,453
2,386,187
2,522,608
2,648,344
2,782,536
2,887,252
455,453
455,4532,887,2522,782,5362,648,3442,522,6082,386,1872,258,4532,141,8832,010,4491,877,9401,780,9331,635,9201,515,5671,407,2231,316,1151,254,7551,189,6411,116,8731,086,3591,016,505948,910879,775841,835785,948769,307753,585745,341694,889676,166662,615645,692612,308585,059555,323515,784481,230456,326423,420400,392366,761342,066310,973281,734242,264219,015178,993152,734126,859104,87687,29071,16151,1603,068-7,168-5,1802,1233,2673,0442,8892,0581,359894
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
305,956
20
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
2,101,582
0
02,101,5822,101,5822,101,5822,101,5822,101,5822,101,5822,101,5822,101,5822,101,5822,101,5822,101,5822,101,5822,101,58220305,9560000000000000000000000000000000000000000000000
   Treasury Stock00-2,815-2,815-2,815-2,815-2,815-2,815-2,815-2,815-2,815-2,815-2,815-2,815-59000-433-423-415-59-405-422-424-437-435-443-454-454-454-459-454-453-465-460-459-453-452-11,564-4,846000000000000000000000
   Other Stockholders Equity 
205,618
202,494
199,631
194,547
186,778
182,570
182,323
145,458
145,680
0
573,660
697,834
719,329
728,983
727,911
910,316
910,316
907,161
873,535
866,581
865,654
834,866
792,979
795,406
795,406
795,406
795,406
795,406
795,406
795,406
795,406
797,898
811,863
825,960
840,811
855,960
870,839
886,160
901,716
917,912
933,602
1,964,591
1,984,242
2,003,879
2,051,051
2,051,051
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
2,098,767
314,240
314,2402,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,098,7672,051,0512,051,0512,003,8791,984,2421,964,591933,602917,912901,716886,160870,839855,960840,811825,960811,863797,898795,406795,406795,406795,406795,406795,406795,406795,406792,979834,866865,654866,581873,535907,161910,316910,316727,911728,983719,329697,834573,6600145,680145,458182,323182,570186,778194,547199,631202,494205,618



5.4. Balance Sheets

Currency in CNY. All numbers in thousands.




5.5. Cash Flows

Currency in CNY. All numbers in thousands.




5.6. Income Statements

Currency in CNY. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2022-03-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,243,255
Cost of Revenue-183,307
Gross Profit1,059,9481,059,948
 
Operating Income (+$)
Gross Profit1,059,948
Operating Expense-451,083
Operating Income608,865608,865
 
Operating Expense (+$)
Research Development22,296
Selling General Administrative187,062
Selling And Marketing Expenses241,725
Operating Expense451,083451,083
 
Net Interest Income (+$)
Interest Income32,609
Interest Expense-38,561
Other Finance Cost-38,561
Net Interest Income32,609
 
Pretax Income (+$)
Operating Income608,865
Net Interest Income32,609
Other Non-Operating Income Expenses0
Income Before Tax (EBT)627,835589,895
EBIT - interestExpense = 570,304
619,417
539,626
Interest Expense38,561
Earnings Before Interest and Taxes (EBIT)608,865666,396
Earnings Before Interest and Taxes (EBITDA)628,778
 
After tax Income (+$)
Income Before Tax627,835
Tax Provision-118,352
Net Income From Continuing Ops509,483509,483
Net Income501,065
Net Income Applicable To Common Shares501,065
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses634,390
Total Other Income/Expenses Net18,970-32,609
 

Technical Analysis of Global Cord Blood Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Global Cord Blood Corp. The general trend of Global Cord Blood Corp is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Global Cord Blood Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Global Cord Blood Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.15 < 1.15 < 1.15.

The bearish price targets are: 0.25 > 0.021 > 0.021.

Tweet this
Global Cord Blood Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Global Cord Blood Corp. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Global Cord Blood Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Global Cord Blood Corp. The current macd is 0.00778599.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Global Cord Blood Corp price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Global Cord Blood Corp. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Global Cord Blood Corp price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Global Cord Blood Corp Daily Moving Average Convergence/Divergence (MACD) ChartGlobal Cord Blood Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Global Cord Blood Corp. The current adx is 18.59.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Global Cord Blood Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Global Cord Blood Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Global Cord Blood Corp. The current sar is 0.39962701.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Global Cord Blood Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Global Cord Blood Corp. The current rsi is 50.93. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Global Cord Blood Corp Daily Relative Strength Index (RSI) ChartGlobal Cord Blood Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Global Cord Blood Corp. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Global Cord Blood Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Global Cord Blood Corp Daily Stochastic Oscillator ChartGlobal Cord Blood Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Global Cord Blood Corp. The current cci is 35.47.

Global Cord Blood Corp Daily Commodity Channel Index (CCI) ChartGlobal Cord Blood Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Global Cord Blood Corp. The current cmo is 3.29162634.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Global Cord Blood Corp Daily Chande Momentum Oscillator (CMO) ChartGlobal Cord Blood Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Global Cord Blood Corp. The current willr is -14.44444444.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Global Cord Blood Corp Daily Williams %R ChartGlobal Cord Blood Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Global Cord Blood Corp.

Global Cord Blood Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Global Cord Blood Corp. The current atr is 0.1120318.

Global Cord Blood Corp Daily Average True Range (ATR) ChartGlobal Cord Blood Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Global Cord Blood Corp. The current obv is 1,926,940.

Global Cord Blood Corp Daily On-Balance Volume (OBV) ChartGlobal Cord Blood Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Global Cord Blood Corp. The current mfi is 74.54.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Global Cord Blood Corp Daily Money Flow Index (MFI) ChartGlobal Cord Blood Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Global Cord Blood Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Global Cord Blood Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Global Cord Blood Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.931
Ma 20Greater thanMa 500.961
Ma 50Greater thanMa 1001.019
Ma 100Greater thanMa 2001.125
OpenGreater thanClose1.020
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Global Cord Blood Corp with someone you think should read this too:
  • Are you bullish or bearish on Global Cord Blood Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Global Cord Blood Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Global Cord Blood Corp

I send you an email if I find something interesting about Global Cord Blood Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Global Cord Blood Corp.

Receive notifications about Global Cord Blood Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.